Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $25.1B |
| FY2017, ended Dec 31, 2017 | $35.8B |
| FY2018, ended Dec 31, 2018 | $26.7B |
| FY2019, ended Dec 31, 2019 | $34.1B |
| FY2020, ended Dec 31, 2020 | $48.8B |
| FY2021, ended Dec 31, 2021 | $50.8B |
| FY2022, ended Dec 31, 2022 | $53.0B |
| FY2023, ended Dec 31, 2023 | $60.0B |
| FY2024, ended Dec 31, 2024 | $51.1B |
| FY2025, ended Dec 31, 2025 | $75.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $94.2B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.05B |
| FY2017, ended Dec 31, 2017 | $3.37B |
| FY2018, ended Dec 31, 2018 | $3.81B |
| FY2019, ended Dec 31, 2019 | $4.20B |
| FY2020, ended Dec 31, 2020 | $4.60B |
| FY2021, ended Dec 31, 2021 | $5.54B |
| FY2022, ended Dec 31, 2022 | $6.31B |
| FY2023, ended Dec 31, 2023 | $7.14B |
| FY2024, ended Dec 31, 2024 | $7.49B |
| FY2025, ended Dec 31, 2025 | $8.29B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $9.22B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $713M | $602M |
| FY2017, ended Dec 31, 2017 | $821M | $904M |
| FY2018, ended Dec 31, 2018 | $993M | $1.10B |
| FY2019, ended Dec 31, 2019 | $1.11B | $1.01B |
| FY2020, ended Dec 31, 2020 | $1.41B | $1.32B |
| FY2021, ended Dec 31, 2021 | $1.38B | $1.11B |
| FY2022, ended Dec 31, 2022 | $1.19B | $699M |
| FY2023, ended Dec 31, 2023 | $1.63B | $1.50B |
| FY2024, ended Dec 31, 2024 | $1.51B | $1.66B |
| FY2025, ended Dec 31, 2025 | $1.91B | $1.97B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.13B | $2.10B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $378M |
| FY2017, ended Dec 31, 2017 | $529M |
| FY2018, ended Dec 31, 2018 | $638M |
| FY2019, ended Dec 31, 2019 | $798M |
| FY2020, ended Dec 31, 2020 | $1.18B |
| FY2021, ended Dec 31, 2021 | $1.33B |
| FY2022, ended Dec 31, 2022 | $1.31B |
| FY2023, ended Dec 31, 2023 | $2.30B |
| FY2024, ended Dec 31, 2024 | $1.53B |
| FY2025, ended Dec 31, 2025 | $2.09B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.19B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | — |
| FY2020, ended Dec 31, 2020 | — |
| FY2021, ended Dec 31, 2021 | — |
| FY2022, ended Dec 31, 2022 | — |
| FY2023, ended Dec 31, 2023 | $0 |
| FY2024, ended Dec 31, 2024 | $374M |
| FY2025, ended Dec 31, 2025 | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 13.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 2.27B |
| FY2017, ended Dec 31, 2017 | 2.27B |
| FY2018, ended Dec 31, 2018 | 2.17B |
| FY2019, ended Dec 31, 2019 | 2.15B |
| FY2020, ended Dec 31, 2020 | 2.11B |
| FY2021, ended Dec 31, 2021 | 2.12B |
| FY2022, ended Dec 31, 2022 | 2.09B |
| FY2023, ended Dec 31, 2023 | 2.08B |
| FY2024, ended Dec 31, 2024 | 1.95B |
| FY2025, ended Dec 31, 2025 | 1.96B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.96B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.25B | $45.8M | $16.4M |
| FY2017, ended Dec 31, 2017 | $361M | $52.3M | $52.6M |
| FY2018, ended Dec 31, 2018 | $1.34B | $57.1M | $27.9M |
| FY2019, ended Dec 31, 2019 | $707M | $63.4M | $92.4M |
| FY2020, ended Dec 31, 2020 | $596M | $70.3M | $72.9M |
| FY2021, ended Dec 31, 2021 | $13.8M | $70.5M | $45.7M |
| FY2022, ended Dec 31, 2022 | $771M | $64.1M | $64.0M |
| FY2023, ended Dec 31, 2023 | $659M | $68.8M | $130M |
| FY2024, ended Dec 31, 2024 | $3.77B | $91.0M | $79.0M |
| FY2025, ended Dec 31, 2025 | $104M | $126M | $165M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $221M | $136M | $156M |
Valuation
At current price- Market Cap
- $89.0B
- P/E
- 41.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 9.7×
- Price / Book
- 9.5×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $9.22B
- Revenue Growth YoY
- 20.4%
- Revenue CAGR 3Y
- 9.5%
- Revenue CAGR 5Y
- 12.5%
- EPS Growth YoY
- —. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- 35.2%
Profitability
Trailing 12 months- Gross Margin
- 55.5%
- Operating Margin
- 29.2%
- Net Margin
- 23.1%
- FCF Margin
- 22.8%
- Return on Equity
- 25.7%
Earnings
Trailing 12 months- Net Income
- $2.13B
- EPS (diluted)
- —
- EBITDA
- $2.81B
- Operating Income
- $2.69B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $2.19B
- Total Debt
- —. Short- and long-term borrowings, excluding leases
- Net Cash
- —. Cash − total debt
- Total Assets
- $11.4B
- Total Liabilities
- $2.02B
- Shareholders' Equity
- $9.36B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $2.24B
- Capital Expenditure
- $141M
- Free Cash Flow
- $2.10B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 0.49
Every ratio is calculated from the company’s reported figures.